Neuralink Corp., Elon Musk’s brain-computer interface startup, today announced that it has closed a $650 million funding ...

At least 11 investment firms, including ARK Investment Management, Founders Fund and Sequoia Capital, participated in the ...

Paradromics completes first human BCI implant, setting stage for clinical trials targeting severe motor impairment.

Paradromics, a competitor of Neuralink, announced Monday it safely implanted a brain-computer interface into a human patient ...

It closed its funding round with participation from key investors including ARK Invest, DFJ Growth, Founders Fund, G42, Human ...

Elon Musk’s startup deepens ambitions in human-AI integration amid growing competition from Paradromics and others Neuralink, ...

Paradromics implanted—then removed—the device in an epileptic patient. The goal is to help people with conditions like ALS.

Neuralink is building a brain-computer interface, or BCI, which is a system that translates brain signals into commands for ...

Neuralink competitor Paradromics plans to conduct the first clinical trial of its Connexus brain implant later this year.

Paradromics Inc. completed its first human procedure with the Connexus BCI, marking a milestone in brain-computer interface ...

Paradromics implanted its first brain implant device, Connexus, in a human patient last month, successfully recording ...